Nascent Pharma Holdings, Inc.

CIK 2042814 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nascent Pharma Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Apr 10, 2026D0002042814-26-000004
Jul 17, 202515-12G0001641172-25-020011
Mar 28, 2025NT 10-K0001641172-25-001157
Oct 28, 20248-K12G30001493152-24-042727